Are SENS insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies SENS leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Stock Ratings / Health Care / SENS / insiders

ANGO (36) SGHT (39) DCTH (59) TCMD (67) ⌘ Pro Terminal →

Senseonics Holdings Inc. (SENS) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$8.98 -5.57% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $8.87

Senseonics Holdings Inc. (SENS) carries a Roarable Rating of D- (Sell) with 40/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $502.8M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SENS Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SENS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Senseonics Holdings Inc. (NASDAQ: SENS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $8.98 (-5.57% 1D, market cap $502.8M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, SENS ranks #460 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SENS compare to ANGO and SGHT in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), SENS carries a Roarable D- (40/100 RQD), trailing P/E of N/A, gross margin of 44.7%, and ROIC of -35.0%. By comparison, ANGO (AngioDynamics Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M) and SGHT (Sight Sciences Inc.) posts a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $513.4M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SENS?

▼

Per SENS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001616543), Senseonics Holdings Inc. generated $35.3M in revenue (+56.9% YoY), -$69.1M in net income, and -$59.1M in free cash flow against $126.3M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $8.87 (-1.19%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-8.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SENS)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (40/100 Composite)

🔍 WHY SENS SCORES 40/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (38% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (20% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$8.92-8% Next Q

Q2 (-2Q)

Grade E$8.21+1.5% Next Q

Q3 (-1Q)

Grade E$8.33+7.8% Next Q

Current

Grade D-$8.98-7.4% Hist 90D α

Trajectory: E (32) → D- (40)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SENS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SENS currently carries a cautious 40/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Big institutional funds and options desks are actively positioning on the bullish side.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.19) and Max Pain ($9.43) forces dealer call-delta covering toward $11.17.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SENS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “SENS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 40%NO 60%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

SENS Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (SENS)

No recent open-market Form 4 cluster sales or emergency dumps flagged on SENS. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SENS)

✓Walkthrough of SENS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SENS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +79.24%▲ ASCENDING CHANNEL

2026-11-03O $9.75H $9.75L $8.98C $8.98VOL 988.6K

RES: $11.24SUP: $7.51SMA50: $9.19SMA200: $7.22

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SENS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SENS Butterfly Map → + Track SENS →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +56.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on SENS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SENS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SENS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SENS)

Health Care Rank #460 of 1015 ⚔️ ANGO vs SENS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SENS vs. ANGO, SGHT, DCTH, TCMD)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Senseonics Holdings Inc. (SENS) ranks #460 by composite RQD confidence (40/100, grade D-) and #441 by equity capitalization ($502.8M). Within this direct 5-issuer industry benchmark cohort, TCMD leads on earnings valuation at 28.9x trailing P/E, while TCMD leads on capital efficiency and profitability with 17.1% ROIC and 75.9% gross margin. TCMD currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with SENS at 40/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SENS ACTIVE Senseonics Holdings Inc.	D-	40/100	—	44.7%	-35.0%	-5.57%	$502.8M	Benchmark Subject
ANGO AngioDynamics Inc.	D-	36/100	—	54.6%	-23.4%	-1.92%	$504.2M	/ango-vs-sens →
SGHT Sight Sciences Inc.	D-	39/100	—	86.2%	-35.0%	-1.82%	$513.4M	/sght-vs-sens →
DCTH Delcath Systems Inc.	C-	59/100	—	86.2%	0.8%	+1.78%	$487.2M	/dcth-vs-sens →
TCMD Tactile Systems Technology Inc.	C+	67/100	28.9x	75.9%	17.1%	-0.74%	$521.9M	/tcmd-vs-sens →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001616543 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Senseonics Holdings Inc. (SENS) reported GAAP revenue of $35.3M (+56.9% vs. FY2024 revenue of $22.5M , and +57.5% cumulative change since FY2023) , GAAP net income of -$69.1M, operating cash flow of -$59.1M, and free cash flow of -$59.1M (+2.2% YoY). On the balance sheet, SENS closed FY2025 with $126.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$35.3M	-$69.1M	-$59.1M	-$59.1M	$126.3M	—
FY2024 (FY)	2024-12-31	$22.5M	-$78.6M	-$60.5M	-$60.5M	$100.4M	—
FY2023 (FY)	2023-12-31	$22.4M	-$60.4M	-$70.2M	-$70.2M	—	—

3. SENS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SENS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does SENS compare to ANGO and SGHT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for SENS?

Where is SENS trading relative to its 50-day, 200-day, and 52-week technical levels?

SENS last traded at $8.98 (-5.57% on volume of 573,531 shares), positioning the stock -2.29% below its 50-day simple moving average ($9.19) and +24.38% above its 200-day simple moving average ($7.22). Across its 52-week range of $4.79 to $10.64, SENS sits at the 71.6% percentile with a 14-day RSI of 57.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($7.86 to $10.10).

Direct Sub-Reports: SENS RQD Cockpit SENS 12M Forecast SENS Earnings & Move SENS Dividends & DRIP SENS Insiders & 13F SENS Whale Options SENS Profit Sankey SENS News & Why

ROARABLE RATING BRIEF • RQD 40/100 (D-) ✓ SEC XBRL & RQD VERIFIED

SENS — Senseonics Holdings Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Senseonics Holdings Inc. (SENS) earns a live Roarable RQD composite score of 40/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $8.98 (-5.57% 1D, market capitalization $502.8M).

Fundamental Cash Engine (6/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 44.7%, operating margin of -60.0%, and free cash flow yield of -11.47%.
Whale 13F & Options Flow (15/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Senseonics Holdings Inc. Is a NASDAQ-listed issuer in the Health Care sector, specifically Medical/Dental Instruments..5B. Per the market data, its gross margin is 44.7%, indicating that product-level economics are positive before operating costs..

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Senseonics Holdings Inc. (SENS) reported $35.3M in annual revenue (up from $22.5M in FY2024, +56.9% YoY) and -$69.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($22.4M revenue, -$60.4M net income) through FY2025, SENS scaled operating cash flow to -$59.1M and free cash flow to -$59.1M, backed by $126.3M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (D- • RQD 40/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of -11.47% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 6/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $4.79 – $10.64 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream component suppliers, downstream distributors, and sector correlations therefore cannot be mapped from the source data.

Key Question #1: Can SENS sustain or expand its -60.0% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $35.3M and free cash flow of -$59.1M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is SENS's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

SENS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Senseonics Holdings Inc. (SENS) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to SENS Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance Australia • 21h ago

Senseonics Holdings, Inc. (SENS) stock price, news, quote and history

Yahoo Finance Australia report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

A maker of implantable glucose monitors has two November talks in New York.

Stock Titan report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago

Senseonics Holdings, Inc. (SENS) Interactive Stock Chart

Yahoo! Finance Canada report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Kalkine Media • 1d ago

Why Senseonics (NYSE:SENS) Is Back on the Market’s Radar?

Kalkine Media report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

A one-year diabetes monitor designed without an external transmitter enters human testing

Stock Titan report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 1d ago

Barclays sets USD 10 target for Senseonics Holdings stock

ad-hoc-news.de report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

BlackRock reports sole voting power over 2.7M Senseonics (SENS) shares in a passive stake update.

Stock Titan report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST https://www.dars.gov.et/ • 1d ago

SENS Q2 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Shares - Earnings Growth Analysis

https://www.dars.gov.et/ report covering Senseonics Holdings Inc. (SENS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SENS Bull vs. Bear Conversation Board — What's Your Call at $8.98?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SENS 🐻 33% BEARISH CONVICTION

DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $11.22 (+18.0%)

📌 Pinned Debate

Institutional accumulation and options positioning score 15 of 20 and revenue grew from $22.4M in FY 2023 to $35.3M in FY 2025.

Here is why I am bullish on SENS here at $9.51: Institutional accumulation and options positioning score 15 of 20 and revenue grew from $22.4M in FY 2023 to $35.3M in FY 2025.. Compare SENS's -60.0% operating margin and -35.0% ROIC against the rest of Medical/Dental Instruments. As long as cash conversion holds up, dips toward $9.03 are getting bought.

VolSurface_Trader 🐂 BULL

Both sides have a point here — SENS's 8/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $7.70 (-19.0%)

Spot @ $9.51

Operating margin of -60% and ROIC of -35% with cash falling from $74.6M to $40.2M in one year signal an unsustainable burn.

Sitting on the sidelines or leaning short SENS above $9.51. Operating margin of -60% and ROIC of -35% with cash falling from $74.6M to $40.2M in one year signal an unsustainable burn.. Until Fundamental Cash Engine (6/20) and FCF yield (-11.47%) inflect higher, upside is capped near $10.64.